should you stop tirzepatide before surgery Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Can I Have Plastic Surgery

AMPK - AMP-Activated Protein Kinase

If any of the remaining TRIUMPH trials fail to meet their primary endpoints, Lilly may need to redesign or repeat studies

Together, were advancing towards a future where health solutions are not only cutting-edge but accessible and tailored to diverse needs

Study Design 441 adults with obesity received tirzepatide for 60 weeks Participants who achieved meaningful weight loss were then randomized for another 52 weeks to: Continue maximum tolerated dose (1015 mg) Reduce to 5 mg Switch to placebo Weight Loss at Week 112 Continued max dose: 21.9% total body weight Reduced to 5 mg: 16.6% Placebo/discontinuation: 9.9% Weight regain was common after stopping therapy Participants regaining 50% of lost weight: 8% on continued max dose 25% on 5 mg 67% after discontinuation Cardiometabolic benefits were also maintained Including improvements in: Waist circumference Blood pressure Glycemia Lipid profile so whats the best for patients after hitting the target weight loss

Surgeons need metabolic status, anesthesiologists require drug profiles, and primary care/endocrinology must set targets and titrate meds